{
    "BIDSVersion": "1.6.0",
    "License": "CC0",
    "Name": "Positron emission tomography (PET) quantification in rats of cyclooxygenase-2 (COX-2), a potential biomarker of neuroinflammation",
    "Authors": [
        "Xuefeng Yan1, Martin Noergaard1,2, Cheryl L. Morse1, Jeih-San Liow1, Jinsoo Hong1,  Douglas Greve3, Sanjay Telu1, Min-Jeong Kim1, Jose A. Montero Santamaria1, Anthony Galassi1, Ningping Feng1, Sarah K. Williams Avram1, Ted B. Usdin1, Shawn Wu1, Andrea Zhang1, Lester S. Manly1, Madeline Jenkins1, Maia Van Buskirk1, Adrian Lee1, Sami S. Zoghbi1, Victor W. Pike1, Paolo Zanotti-Fregonara1, and Robert B. Innis*1"
    ],
    "Acknowledgements": "NA",
    "HowToAcknowledge": "Martin Norgaard",
    "Funding": [
        "ZIA-MH002852 (RBI)/NIH/Intramural NIH HHS/United States",
        "ZIA-MH002793 (RBI)/ImNIH/Intramural NIH HHS/United States",
        "NCT03912428 (RBI)/ImNIH/Intramural NIH HHS/United States",
        "NCT04396873 (RBI)/ImNIH/Intramural NIH HHS/United States"
    ],
    "DatasetDOI": "doi:10.18112/openneuro.ds005605.v1.0.0",
    "ReferencesAndLinks": [],
    "EthicsApprovals": [
        "Animal studies adhered strictly to the National Institute of Mental Health Animal Care and Use Committee guidelines and conformed to the Institute of Medicineâ€™s recommendations for laboratory animal care standards. The human component received approval from the National Institutes of Health (NIH) Combined Neurosciences Institutional Review Board (protocol numbers: 19-M-0079 and 20-M-0082; ClinicalTrials.gov identifiers: NCT03912428 and NCT04396873)."
    ]
}